Viemed (VMD) Director Kaushal Nitin Converts 18,786 RSUs to Shares

What Happened

• Kaushal Nitin, a director of Viemed Healthcare (VMD), had 18,786 derivative units converted into common shares on August 19, 2026 (reported as an exercise/conversion). No cash was paid or received in the reported entries ($0 or N/A reported). Separately, he was granted 15,217 Restricted Stock Units (RSUs) on August 17, 2026.

Key Details

• Transactions and reported prices:
  • Aug 19, 2026: Exercise/conversion (derivative, code M) — 18,786 shares; one entry shows acquisition with price N/A, another shows disposition of derivative at $0.00 (reported $0 value).
  • Aug 17, 2026: Grant/award (code A) — 15,217 RSUs at $0.00 (RSUs are contingent awards).
• Shares owned after the transaction: Not specified in the provided filing excerpt.
• Footnotes of note:
  • F1: Each RSU represents a contingent right to one common share.
  • F2: The converted/vesting RSUs were originally granted Aug 19, 2025 and vested Aug 19, 2026.
  • F3: The Aug 17, 2026 RSU grant vests on Aug 17, 2027.
• Filing timeliness: Report filed Aug 19, 2026 for transactions through Aug 17–19, 2026; timing appears consistent with standard Form 4 reporting windows (no late-filing flag included in the provided data).

Context

• These entries reflect RSU vesting and conversion into shares (derivative exercise/conversion), not an open-market sale or purchase. The reported $0/N/A values indicate shares were issued upon vesting/settlement rather than bought or sold for cash.
• New RSUs granted on Aug 17, 2026 are time-vesting awards and will only convert into shares if/when they vest (Aug 17, 2027 per the footnote).